South Africa has voluntarily suspended the rollout of Johnson & Johnson vaccine following the announcement made by the Food and Drug Administration to temporarily suspend the J&J vaccine in the US after reports of six females developing blood clots with low platelets there .

South Africa suspends Johnson & Johnson coronavirus vaccine amid clot concerns

The US Food and Drug Administration announced that they are temporarily halting use of Johnson & Johnson’s COVID-19 vaccine after developing six cases of rare blood-clotting in the country, that left one woman dead and another in critical condition.

Temporary halt on Johnson & Johnson vaccination in US over blood clot concerns

The Food and Drug Administration of the US government said on Tuesday it is asking states to temporarily halt using Johnson & Johnson’s Covid-19 vaccine after six people in the country developed a rare blood clotting disorder.

US halts use of Johnson & Johnson vaccine due to rare blood clotting issues

European drug regulators are undertaking review of rare blood clots in four people in the United States of America who have received Johnson & Johnson COVID-19 vaccine.

Johnson & Johnson vaccine review follows blood clot cases

Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country.

J&J's single-dose vaccine trial in India?

While the third-world countries are struggling to get coronavirus vaccine, a factory in the US ruined nearly 15 million doses of the Johnson & Johnson coronavirus vaccines.

US: 15 million doses of Johnson & Johnson coronavirus vaccine destroyed

After several countries imposed a temporary suspension on AstraZeneca's coronavirus vaccine, the World Health Organization (WHO) has backed the use of this vaccine.

WHO backs use of AstraZeneca vaccine; approves J&J for COVID variants

Health Minister Jens Spahn said Friday that Germany would have to wait until "mid-to-late April" for the newly approved Johnson & Johnson coronavirus vaccine, adding that the EU is querying the company over the delays.

Germany expects Johnson & Johnson jabs only in April

Europe has approved Johnson & Johnson's single-dose vaccine and the first shot is expected to be delivered in the month. Previously vaccine from Pfizer, BioNTech, AstraZeneca Oxford and Moderna had been endorsed by the European Union, however, Johnson & Johnson is the first single-shot vaccine to be approved.

European Union approves Johnson & Johnson's single-shot vaccine

The European Union on Thursday approved Johnson & Johnson's single-dose coronavirus vaccine, as the bloc seeks to speed up a stuttering inoculation campaign and boost its supplies of vaccines.

European Union gives green light to Johnson & Johnson's COVID-19 vaccine

A temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines by companies such as the Serum Institute of India (SII), its chief executive said in a World Bank panel discussion on Thursday.

Indian vaccine giant SII warns of supply hit from US raw materials export ban

In a bid to meet the set targets for coronavirus vaccine, US President Joe Biden has made a significant announcement promising vaccination for all adults by the end of May.

Adult population of US to be vaccinated by May: Joe Biden

The Centres for Disease Control & Prevention has sent out a stern warning of the possibility of the 4th wave of COVID-19 infections in the United States. This has come at a time when the National Public Health Institute has given the green signal to Johnson & Johnson's COVID-19 vaccine.

Despite vaccines, CDC warns of a 4th wave of COVID-19 in US

Johnson & Johnson's COVID-19 vaccine has become embroiled in a controversy as the Catholic Archdiocese of New Orleans have labelled it as “morally compromised” over links to abortion cells.

Johnson & Johnson vaccine gets embroiled in controversy over abortion cells

The coronavirus vaccines were being hailed as lifesaver and people had assumed that the inoculation drives will bring immediate relief in the pandemic struggles.

Potential 'fourth surge' of coronavirus possible soon, CDC chief warns

A day after the US authorised Johnson & Johnson's coronavirus vaccine for emergency use, the authorities are now hoping that four million doses of the vaccine will be delivered across the country as early as Tuesday.

US to get 4 million J&J vaccine by Tuesday; Fauci hopes to vaccinate children by 2021 end

On Saturday, the US authorised Johnson & Johnson's coronavirus vaccine for emergency use, making it the third approved vaccine of the county since the outbreak of COVID-19 a year ago.

As US approves Johnson & Johnson coronavirus vaccine, Biden warns Americans

South Africa's second tranche of 80,000 Johnson & Johnson COVID-19 vaccine from Brussels touched down at OR Tambo International airport on Saturday morning. The second batch of vaccines is reserved for frontline healthcare workers.

South Africa receives second batch of J&J vaccines

The food and drug administration of the US has now said that Johnson & Johnson's one shot Corona vaccine appears to be safe and effective in the trial.

FDA paves way for Johnson & Johnson's one-shot COVID-19 vaccine approval for emergency use

South Africa will continue with the planned phase 1 vaccination using the Johnson & Johnson, Health Minister, Zweli Mkhize said today. “Given the outcomes of the efficacy studies, the Department of Health will continue with the planned phase 1 vaccination using the Johnson & Johnson vaccine instead of the AstraZeneca vaccine,” the Minister said in a virtual briefing on Wednesday morning.

South Africa to proceed with planned phase 1 vaccination using J&J

South Africa faces a serious setback as scientists and experts announced that AstraZeneca vaccine is less effective against 501.Y.V2 covid variant first found in South Africa.

South Africa halts AstraZeneca vaccinations over variant data

Johnson & Johnson on Thursday applied for emergency use authorisation of its single-dose coronavirus vaccine to US health regulators. If approved, the vaccine will be third for the worst-hit United States, the country which has seen over 450,000 deaths due to the deadly virus.

Johnson & Johnson seeks emergency use authorisation for its Covid-19 vaccine

Johnson & Johnson Coronavirus vaccine has shown an overall 66% efficacy in preventing moderate to severe COVID-19. Although the trial results indicate that it is less effective against the virus variant first discovered in South Africa.

Single-dose Johnson & Johnson Coronavirus vaccine shows 66% efficacy

Johnson & Johnson expects to release critical results from its COVID-19 vaccine trial in as little as two weeks — a potential boon in the effort to protect Americans from the coronavirus — but most likely won’t be able to provide as many doses this spring as it promised the federal government because of unanticipated manufacturing delays.

Johnson & Johnson expects vaccine results soon but lags in production

johnson-johnson

Johnson & Johnson, News on Johnson & Johnson, stories on Johnson & Johnson, articles on Johnson & Johnson, Johnson & Johnson stories at Wion, Johnson & Johnson news, Johnson & Johnson latest news

johnson johnson